These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 10893961)

  • 1. [Long-term success in routine clinical practice. Effectiveness trial passed].
    MMW Fortschr Med; 2000; 142(3 Suppl):30-1. PubMed ID: 10893961
    [No Abstract]   [Full Text] [Related]  

  • 2. [Positive change from protease inhibitor to non-nucleoside reverse transcriptase inhibitor efavirenz. Improved virus control thanks to protease inhibitor switch].
    MMW Fortschr Med; 2001 Apr; 143 Suppl 1():37-8. PubMed ID: 11373775
    [No Abstract]   [Full Text] [Related]  

  • 3. [A "once daily" drug that with proven effectiveness. Efavirenz has successful outcome also in direct comparisons].
    MMW Fortschr Med; 2003 Apr; 145 Spec No 1():12-3. PubMed ID: 15011576
    [No Abstract]   [Full Text] [Related]  

  • 4. Dose-ranging studies.
    Manion D
    Int J Clin Pract Suppl; 1999 Jun; 103():8-9. PubMed ID: 10622036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 48-week data released for combination treatment with efavirenz.
    AIDS Patient Care STDS; 1999 Jul; 13(7):438-40. PubMed ID: 10870602
    [No Abstract]   [Full Text] [Related]  

  • 6. Skin eruption 8 days after a single dose of efavirenz-containing combination therapy.
    Yazaki H; Kikuchi Y; Oka S
    Jpn J Infect Dis; 2001 Dec; 54(6):246-7. PubMed ID: 11862010
    [No Abstract]   [Full Text] [Related]  

  • 7. New once-daily HIV combination better tolerated.
    Expert Rev Anti Infect Ther; 2004 Dec; 2(6):826. PubMed ID: 15566325
    [No Abstract]   [Full Text] [Related]  

  • 8. [Progress in HIV therapy. Effective and simple therapy with efavirenz].
    MMW Fortschr Med; 2001 Apr; 143 Suppl 1():36-7. PubMed ID: 11373774
    [No Abstract]   [Full Text] [Related]  

  • 9. Sustiva added to three-drug combination.
    AIDS Patient Care STDS; 1998 Oct; 12(10):803. PubMed ID: 11362030
    [No Abstract]   [Full Text] [Related]  

  • 10. [HIV infection: DuPont Pharma presents the results of its antiretroviral agent].
    Allerg Immunol (Paris); 1998 Apr; 30(4):123-4. PubMed ID: 9631694
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy and safety of the combination of efavirenz and abacavir in HIV-infected patients failing antiretroviral therapy.
    Tenorio AR; Irlanda IE; Narkiewicz E; Smith KY; Kessler HA; Sha BE
    AIDS; 2000 Jul; 14(10):1470-1. PubMed ID: 10930173
    [No Abstract]   [Full Text] [Related]  

  • 12. New expanded access drugs for use in combination therapy.
    Notes Undergr; 1998; (No 37):suppl 1-2. PubMed ID: 11365823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [3 years' data of tenofovir. Confirmed as a valuable building block].
    MMW Fortschr Med; 2004 Apr; 146 Spec No 1():30-1. PubMed ID: 15373042
    [No Abstract]   [Full Text] [Related]  

  • 14. A once-daily combination tablet (Atripla) for HIV.
    Med Lett Drugs Ther; 2006 Sep; 48(1244):78-9. PubMed ID: 17001298
    [No Abstract]   [Full Text] [Related]  

  • 15. Warning on two specific 3-drug regimens: Viread + Didanosine + either Sustiva or Viramune.
    AIDS Treat News; 2004 Oct; (406):5. PubMed ID: 15614963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paediatric treatment issues.
    Walters S
    Int J Clin Pract Suppl; 1999 Jun; 103():26-9. PubMed ID: 10622040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efavirenz shows promising results.
    AIDS Patient Care STDS; 1998 Jan; 12(1):64-5. PubMed ID: 11361892
    [No Abstract]   [Full Text] [Related]  

  • 18. [Lipid profile and body fat--significant "side effect" of antiretroviral therapy. Tenofovir: favorable profile of adverse effects].
    MMW Fortschr Med; 2003 Apr; 145 Spec No 1():83. PubMed ID: 15011603
    [No Abstract]   [Full Text] [Related]  

  • 19. Hypersensitivity syndrome associated with efavirenz therapy.
    Bossi P; Colin D; Bricaire F; Caumes E
    Clin Infect Dis; 2000 Jan; 30(1):227-8. PubMed ID: 10619772
    [No Abstract]   [Full Text] [Related]  

  • 20. Efavirenz + emtricitabine + tenofovir: new combination. HIV infection: do not modify ongoing therapy just to use one less tablet. Better adherence than with separate dosing has not been demonstrated, while reduced efficacy is plausible.
    Prescrire Int; 2009 Jun; 18(101):105. PubMed ID: 19637416
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.